Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-16-000145
Filing Date
2016-11-14
Accepted
2016-11-14 18:52:34
Documents
1
Period of Report
2016-11-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 13609
  Complete submission text file 0000874015-16-000145.txt   15203
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10070 BARNES CANYON ROAD C/O MOLECULAR BIOSYSTEMS INC SAN DIEGO CA 92121
Business Address
HOUGEN ELIZABETH L (Reporting) CIK: 0001074773 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 161997275
SIC: 2835 In Vitro & In Vivo Diagnostic Substances